The advertisement promotes TRODELVY as a potential treatment option for patients, encouraging healthcare professionals to explore more information about the product.
Creative Information
| CID: | b8c4a6e2-e5df-420e-81c8-3d8a322dd498 |
| CRID: | 92_5528:235753 |
| Domain: | gilead.com |
| Seat: | RBC |
| Size: | 320x50 |
| Bid: | $1.14 |
| Timestamp: | 1/4/2026, 2:30:09 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 1/4/2026, 2:30:26 AM | 5.14s | |
| adomain_analysis | success | 1/4/2026, 2:30:13 AM | 2.56s | |
| adomain_capture | success | 1/4/2026, 2:30:10 AM | 0.13s | |
| ad_render | success | 1/4/2026, 2:30:21 AM | 10.84s | |
| brand_mapping | success | 1/4/2026, 2:30:09 AM | 0.11s | |
Analysis Results
| Size: | 320x50 | ||||||||||||||||||||||
| Data Transferred: | 647.62 KB | ||||||||||||||||||||||
| Render Time: | 9.54 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 647.62 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Raw Ad Markup
<div style="width: 0; height: 0; overflow: hidden;"><img border="0" width="1" height="1" src="https://useast-beacon.deepintent.com/impression/9e3f3cac-397c-f762-5310-0e17907c830f?ts=1764126953167&wp=79C4F08F22A85244" alt="" /><img border="0" width="1" height="1" src="https://beacon-iad6.rubiconproject.com/beacon/d/f28218bb-016c-4757-9f19-8bf061a92796?oo=0&accountId=11864&siteId=229562&zoneId=1708178&sizeId=43&e=6A1E40E384DA563BF75D8810E9B47469F2DC7D4982D6A488FE6B8690263810EE90C1BCCB8A9FE9C693754240AC8464D4C3F0B0E82F7A81AFB3D4B93E9C4104DDB9BE0ED34BEEF62D5FC5B167DD54DF0F891430121A396A9395BE9C614A79F562D6F2840C16CEE758104A09295883325C1AB3448FB763A2FC9ACF8C2CB8BCBD6E95BD82A3F8319531FD683D99282092B81669C4E0FF01D69D8226653A0EB082EB927F8EC4F90D764494ADDAFF478AC26A6E91392C4946007C" alt="" /></div>
<span id='deepintent_wrapper_1' onclick=DeepIntentExecuteClicks('')><div style='display:inline-block;position:relative;height:50px'><script type='text/javascript'>document.addEventListener('DOMContentLoaded',function(){setTimeout(function(){new Image().src='https://useast-beacon.deepintent.com/vi?impid=9e3f3cac-397c-f762-5310-0e17907c830f&spanlen='+ (document.getElementById('deepintent_wrapper_span_a-215d-9270-f9c3-ccede29b7a7a').innerHTML.length) + '&spanelemcnt=' + (document.getElementById('deepintent_wrapper_span_a-215d-9270-f9c3-ccede29b7a7a').getElementsByTagName('*').length);},3000)});</script><span id='deepintent_wrapper_span_a-215d-9270-f9c3-ccede29b7a7a'><ins class='dcmads' style='display:inline-block;width:320px;height:50px' data-dcm-placement='N1277702.3848558MATTERKIND/B32908470.426812823' data-dcm-rendering-mode='script' data-dcm-landing-page-escapes='2' data-dcm-click-tracker='https://useast-beacon.deepintent.com/click/9e3f3cac-397c-f762-5310-0e17907c830f?ts=1764126953167&wp=79C4F08F22A85244&loc=1&r=' data-dcm-https-only data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-gdpr-applies='gdpr=' data-dcm-gdpr-consent='gdpr_consent=' data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}' data-dcm-ltd='false' data-dcm-resettable-device-id='' data-dcm-app-id=''> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins> <script src="https://api.b2c.com/api/init-6950yzyceuz7i88zu8vn.js" data-cfasync="false" async></script></span><div id='aeopt' style='position:absolute;z-index:9010;background-color:#CCCCCCCC;top:0;right:0;border-radius:0 0 0 5px;'><div id='aeopti' style='display:block;'><a href='https://www.deepintent.com/adchoices?payload=di_fa5ea8f672f242f1835ad%2C1%2C97.116.58.136%2C4%2C5a915c97-1aca-4268-900e-d544b22830f3%2C135%2Chc_dd6d38f7088e2bac2e72e685aa7ec84b%2C7%2Cff9080654b600793f07b1de5c1b13d26d21ae6a6%2C8%2C84a70d9334408e34557b46e90a085c5e85048ec9eb923377ce444b2095d0bbd2%2C9%2C9FB6EA3DEBB24C64A6EF97119E4AB2F627420E897C2F59F9CF1458882945E404%2C10%2C5jEJJYylEHhiccTtuDYWKrCPhDH33mMMVOOJ0bh9SzA%3D%2C11%2CLV5F00KUSAIBEALSJCSSBTSSPZC3UXAQDXRU%2C12%2CEDI_uWMFtOaZr7olnLFKCxJsOCvopg9W5S0A3W5rnd7WA%252Bvp11ofUkL5x%252FbeCY1w4q7Z%2C14%2CEH_P94t62glIl3hqGa0eQRDK120UJ7%252B9xFJyXqDMiWXdmJ3ZaKh6mVXCJmrr6VQ%252BmxN%2C15%2CXY1364-N1iCwnIDGcOw3ba62QUILWbJmQeps4ZJVtMJQ3U1IY%2C112%2CID5-ZHMONGbygJU1gOtu7Nj9r94_4P_bm1nxs2qJyhb5LA%2C147%2CTH_56083483%2C121%2C6d3918efb135f7e151b2e6918ed6916b' target='_blank' style='display:block;padding:1px 2px 1px 5px;'><img src='https://cdn.deepintent.com/adchoices/di-adchoices.png' alt='AdChoices' border='0' width='13' height='13' style='display:block;'></a></div></div></div></span><script type='text/javascript'>window.DeepIntentExecuteClicks=window.DeepIntentExecuteClicks||function(e){if(e)for(var n=e.split(','),t=0;t<n.length;t++)if(n[t])(new Image).src=n[t]};</script><noscript><img src='https://useast-beacon.deepintent.com/impression/9e3f3cac-397c-f762-5310-0e17907c830f?ts=1764126953167&wp=TRACK' height='0px' width='0px' style='display:none' referrerpolicy='no-referrer-when-downgrade'></noscript><script type="text/javascript">(function(){var r;try{r=window.location.ancestorOrigins[window.location.ancestorOrigins.length-1];}catch(e){}new Image().src='https://useast-beacon.deepintent.com/impression/9e3f3cac-397c-f762-5310-0e17907c830f?ts=1764126953167&wp=TRACK'+((typeof r==='string')?'&rf='+r:'');})();</script><iframe src='https://cdn.deepintent.com/syncpixel.html?_di_cfg=a' width='0' height='0' style='display:none;'></iframe><div style="height:0px;width:0px;overflow:hidden"><iframe src="https://eus.rubiconproject.com/usync.html?&us_privacy=1YNY&geo=na&co=us" frameborder="0" marginwidth="0" marginheight="0" scrolling="NO" width="0" height="0" style="height:0px;width:0px"></iframe></div>
Creatives
